• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

犬尿氨酸羟化酶抑制剂可减轻缺血性脑损伤:在局灶性或全脑缺血模型中使用(间硝基苯甲酰基)-丙氨酸(mNBA)和3,4-二甲氧基-[-N-4-(硝基苯基)噻唑-2-基]-苯磺酰胺(Ro 61-8048)的研究

Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia.

作者信息

Cozzi A, Carpenedo R, Moroni F

机构信息

Department of Preclinical and Clinical Pharmacology, University of Florence, Italy.

出版信息

J Cereb Blood Flow Metab. 1999 Jul;19(7):771-7. doi: 10.1097/00004647-199907000-00007.

DOI:10.1097/00004647-199907000-00007
PMID:10413032
Abstract

Two kynurenine hydroxylase inhibitors, (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfona mide (Ro 61-8048), have been tested as neuroprotective agents on brain lesions induced by bilateral carotid occlusion in gerbils or by middle cerebral artery occlusion in rats. The percentage of lesioned pyramidal neurones found in the hippocampal CA1 region of gerbils subjected to bilateral carotid occlusion for 5 minutes decreased from 92+/-10% in vehicle-treated animals to 7+/-6% after mNBA (400 mg/kg intraperitoneally, three times at 1, 30, and 180 minutes after occlusion) or to 10+/-11% after Ro 61-8048 (40 mg/kg intraperitoneally, three times). A significant reduction in infarct volumes also was found when the kynurenine hydroxylase inhibitors were given to rats after permanent middle cerebral artery occlusion (from 207+/-111 mm3 in vehicle-treated rats to 82+/-18 and to 62+/-57 mm3 in rats treated with mNBA, 400 mg/kg intraperitoneally, or with Ro 61-8048, 40 mg/kg intraperitoneally, respectively). The administration of mNBA (400 mg/kg intraperitoneally) or Ro 61-8048 (40 mg/kg intraperitoneally) to gerbils with a dialysis probe in their dorsal hippocampus or to rats with a dialysis probe in their parietal cortex significantly increased kynurenic acid concentration in the dialysates. The data suggest that inhibition of kynurenine hydroxylase could be a new avenue to reduce neuronal loss in brain ischemia.

摘要

两种犬尿氨酸羟化酶抑制剂,(间硝基苯甲酰基)-丙氨酸(mNBA)和3,4-二甲氧基-[ -N-4-(硝基苯基)噻唑-2-基]-苯磺酰胺(Ro 61-8048),已作为神经保护剂在沙土鼠双侧颈动脉闭塞或大鼠大脑中动脉闭塞诱导的脑损伤模型上进行了测试。在沙土鼠双侧颈动脉闭塞5分钟后,在海马CA1区发现的受损锥体神经元百分比,从溶剂处理组动物的92±10%,在给予mNBA(腹腔注射400mg/kg,在闭塞后1、30和180分钟给药三次)后降至7±6%,或在给予Ro 61-8048(腹腔注射40mg/kg,给药三次)后降至10±11%。当在大鼠永久性大脑中动脉闭塞后给予犬尿氨酸羟化酶抑制剂时,也发现梗死体积显著减小(从溶剂处理组大鼠的207±111mm³,分别降至腹腔注射400mg/kg mNBA或40mg/kg Ro 61-8048处理组大鼠的82±18mm³和62±57mm³)。对背侧海马植入透析探针的沙土鼠或对顶叶皮质植入透析探针的大鼠腹腔注射mNBA(400mg/kg)或Ro 61-8048(40mg/kg),显著增加了透析液中犬尿酸的浓度。数据表明,抑制犬尿氨酸羟化酶可能是减少脑缺血中神经元损失的一条新途径。

相似文献

1
Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia.犬尿氨酸羟化酶抑制剂可减轻缺血性脑损伤:在局灶性或全脑缺血模型中使用(间硝基苯甲酰基)-丙氨酸(mNBA)和3,4-二甲氧基-[-N-4-(硝基苯基)噻唑-2-基]-苯磺酰胺(Ro 61-8048)的研究
J Cereb Blood Flow Metab. 1999 Jul;19(7):771-7. doi: 10.1097/00004647-199907000-00007.
2
Neuroprotective effects of kynurenine-3-hydroxylase inhibitors in models of brain ischemia.犬尿氨酸-3-羟化酶抑制剂在脑缺血模型中的神经保护作用
Adv Exp Med Biol. 1999;467:199-206. doi: 10.1007/978-1-4615-4709-9_26.
3
Quinolinic acid formation in immune-activated mice: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(-3-nitrophenyl)thiazol-2yl]-benzenesul fonamide (Ro 61-8048), two potent and selective inhibitors of kynurenine hydroxylase.免疫激活小鼠体内喹啉酸的形成:使用(间硝基苯甲酰基)-丙氨酸(mNBA)和3,4-二甲氧基-[-N-4-(-3-硝基苯基)噻唑-2-基]-苯磺酰胺(Ro 61-8048)的研究,这两种是犬尿氨酸羟化酶的强效选择性抑制剂。
Neuropharmacology. 1999 Aug;38(8):1225-33. doi: 10.1016/s0028-3908(99)00048-9.
4
Studies on the neuroprotective action of kynurenine mono-oxygenase inhibitors in post-ischemic brain damage.犬尿氨酸单加氧酶抑制剂在缺血性脑损伤后神经保护作用的研究。
Adv Exp Med Biol. 2003;527:127-36. doi: 10.1007/978-1-4615-0135-0_15.
5
Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl)benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase.
J Med Chem. 1997 Dec 19;40(26):4378-85. doi: 10.1021/jm970467t.
6
Kynurenine 3-mono-oxygenase inhibitors attenuate post-ischemic neuronal death in organotypic hippocampal slice cultures.犬尿氨酸3-单加氧酶抑制剂可减轻器官型海马脑片培养物中缺血后的神经元死亡。
J Neurochem. 2002 Sep;82(6):1465-71. doi: 10.1046/j.1471-4159.2002.01090.x.
7
Neuroprotective effect of L-kynurenine sulfate administered before focal cerebral ischemia in mice and global cerebral ischemia in gerbils.硫酸L-犬尿氨酸在小鼠局灶性脑缺血和沙鼠全脑缺血前给药的神经保护作用。
Eur J Pharmacol. 2007 Jun 14;564(1-3):116-22. doi: 10.1016/j.ejphar.2007.02.029. Epub 2007 Feb 23.
8
Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia.在局灶性栓塞性脑缺血大鼠中,缺血后2小时给予两种自由基清除剂α-苯基-N-叔丁基硝酮(PBN)和N-叔丁基-(2-磺酸苯基)硝酮(S-PBN)的神经保护作用。
Exp Neurol. 2000 May;163(1):39-45. doi: 10.1006/exnr.2000.7364.
9
Neuroprotective effect of MnTMPyP, a superoxide dismutase/catalase mimetic in global cerebral ischemia is mediated through reduction of oxidative stress and DNA fragmentation.超氧化物歧化酶/过氧化氢酶模拟物MnTMPyP在全脑缺血中的神经保护作用是通过减轻氧化应激和DNA片段化来介导的。
Eur J Pharmacol. 2007 Apr 30;561(1-3):72-9. doi: 10.1016/j.ejphar.2006.12.039. Epub 2007 Jan 27.
10
Kynurenine 3-mono-oxygenase inhibitors reduce glutamate concentration in the extracellular spaces of the basal ganglia but not in those of the cortex or hippocampus.犬尿氨酸3-单加氧酶抑制剂可降低基底神经节细胞外间隙中的谷氨酸浓度,但不会降低皮质或海马体中的谷氨酸浓度。
Neuropharmacology. 2005 May;48(6):788-95. doi: 10.1016/j.neuropharm.2004.10.019.

引用本文的文献

1
The role of the tryptophan metabolites in gut microbiota-brain axis and potential treatments: a focus on ischemic stroke.色氨酸代谢产物在肠道微生物群-脑轴中的作用及潜在治疗方法:聚焦于缺血性中风
Front Pharmacol. 2025 Jun 10;16:1578018. doi: 10.3389/fphar.2025.1578018. eCollection 2025.
2
Circular RNA SCMH1 suppresses KMO expression to inhibit mitophagy and promote functional recovery following stroke.环状RNA SCMH1抑制KMO表达以抑制线粒体自噬并促进中风后的功能恢复。
Theranostics. 2024 Oct 28;14(19):7292-7308. doi: 10.7150/thno.99323. eCollection 2024.
3
Untargeted metabonomic analysis of a cerebral stroke model in rats: a study based on UPLC-MS/MS.
大鼠脑卒模型的非靶向代谢组学分析:基于超高效液相色谱-串联质谱的研究
Front Neurosci. 2023 Aug 8;17:1084813. doi: 10.3389/fnins.2023.1084813. eCollection 2023.
4
Gram-Scale Preparation of Cannflavin A from Hemp ( L.) and Its Inhibitory Effect on Tryptophan Catabolism Enzyme Kynurenine-3-Monooxygenase.从大麻(L.)中克级制备大麻黄酮A及其对色氨酸分解代谢酶犬尿氨酸-3-单加氧酶的抑制作用。
Biology (Basel). 2022 Sep 28;11(10):1416. doi: 10.3390/biology11101416.
5
Mitochondrial remodeling and ischemic protection by G protein-coupled receptor 35 agonists.G 蛋白偶联受体 35 激动剂对线粒体重构和缺血保护的作用。
Science. 2022 Aug 5;377(6606):621-629. doi: 10.1126/science.abm1638. Epub 2022 Aug 4.
6
The Footprint of Kynurenine Pathway in Cardiovascular Diseases.犬尿氨酸途径在心血管疾病中的印记
Int J Tryptophan Res. 2022 Jun 28;15:11786469221096643. doi: 10.1177/11786469221096643. eCollection 2022.
7
Kynurenine Pathway Metabolites as Potential Clinical Biomarkers in Coronary Artery Disease.犬尿氨酸途径代谢产物作为冠状动脉疾病的潜在临床生物标志物。
Front Immunol. 2022 Feb 8;12:768560. doi: 10.3389/fimmu.2021.768560. eCollection 2021.
8
The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors.犬尿氨酸途径和犬尿氨酸 3-单加氧酶抑制剂。
Molecules. 2022 Jan 2;27(1):273. doi: 10.3390/molecules27010273.
9
Kynurenic acid in neurodegenerative disorders-unique neuroprotection or double-edged sword?犬尿氨酸在神经退行性疾病中的作用——独特的神经保护作用还是双刃剑?
CNS Neurosci Ther. 2022 Jan;28(1):19-35. doi: 10.1111/cns.13768. Epub 2021 Dec 3.
10
The Kynurenine Pathway as a Potential Target for Neuropathic Pain Therapy Design: From Basic Research to Clinical Perspectives.犬尿氨酸途径作为治疗神经性疼痛的潜在靶点:从基础研究到临床视角。
Int J Mol Sci. 2021 Oct 13;22(20):11055. doi: 10.3390/ijms222011055.